RAD51 and central nervous system cancer: To screen risk factors for the clinical survival prediction model for glioma, this study conducted a univariate Cox analysis of overall survival and clinical variables including RAD51 expression, PRS type, Grade, gender, age, radiotherapy, Temozolomide (TMZ) treatment, IDH mutation, 1p19q codeletion, and MGMTp methylation.